Senators press HHS on clinical trial prediction markets
CNBC · RSS · · AI-summarised by FinFlash
Sens. Angela Alsobrooks and Ron Wyden are asking what steps the Department of Health and Human Services has taken to mitigate risks from prediction markets tied to clinical trials and drug approvals. The lawmakers' inquiry targets wagering on binary medical outcomes. For investors, scrutiny of these markets could foreshadow tighter oversight of event-driven trading around biotech catalysts.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.